State Ledger
Company profile

Polaryx Therapeutics, Inc. CIK 2075320

Ticker
PLYX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Paramus, NJ 07652
Fiscal year end
2025 (FY)
Market Data
Close
$2.00
Change
+$0.06
Change %
3.09%
Volume
1,023

PLYX · trading date Oct 9, 2026 · previous close $1.94 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$8.99M
Total assets
$5.17M
Total liabilities
$605.0K
Stockholders' equity
$4.57M
Cash & equivalents
$5.14M
Operating income
-$7.82M
Operating cash flow
-$3.94M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-24. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
11.7%
Equity / assets
88.3%
CapEx / revenue
—
Operating cash flow / net income
0.44×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$8.99M $5.17M $605.0K $4.57M
2024 — -$30.36M $5.00M $289.0K $4.71M
Company Details
SIC code
2834
State of incorporation
WY
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-14
Financials filed via
Form 10-K
filed 2026-03-24

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Paramus, NJ 07652
140 EAST RIDGEWOOD AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:40 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies